The survey is open — participate now!
Avoca, a WCG company, takes pride in providing the industry with insights into trends in clinical research to optimize the execution and quality of clinical trials. This year, our survey aims to understand opinions and experiences as it relates to the final ICH E6 (R3) guidance. We encourage you to participate regardless of your current involvement […]
May 13-14, 2025 | Industry-wide Virtual Event
Now in its 14th year, the AQC Summit will feature thought leaders and executive panels sharing experiences, insights, and actions – charting the future of clinical trials.
April 11, 2025 | 11:00am – 12:00pm EDT
Held the second Friday of every month and open to the industry, this webinar offers a live demonstration of the AQC Knowledge Center.
April 9, 2025 | 11:00am – 12:00pm EDT
Monthly forum open exclusively to Avoca Quality Consortium members.
January 29, 2025 | 11:00am – 12:00pm EST
Join our webinar to understand the impact of these regulatory guidance changes to support successful adoption and get ahead of the curve.
January 28, 2025 | 11:00am – 12:00pm EST
ICH E6 (R3) final is here – let’s dive in! AQC members are invited to an informative session on key updates from E6 R2, R3 draft, and R3 final.
This year, Avoca's research focuses on potential changes in regulatory guidance under ICH E6 (R3) to gain understanding of current awareness and perceived impacts among clinical trial stakeholders to navigate the path forward.
Access The 2024 Avoca State of the Industry Report:
Anticipating ICH E6 (R3): Awareness, Impact & Preparedness